DNA Valley

Capturing the Thriving Gene and Cell Therapy Revolution in Maryland

youtube-video-thumbnail

About DNA Valley

 

Maryland is home to both the Human Genome Project, which successfully sequenced the human genome, and the National Institutes of Health, the United States' most prestigious research institution. It is no surprise the State is at the heart of the first cell and gene therapy revolution that is producing cures to previously untreatable diseases. With over 2,700 life science firms, Maryland is on its way to becoming the “DNA Valley” of the United States.

 

AGT “DNA Valley” series will highlight cutting-edge cell and gene therapy products, technologies, and platforms in use or in development by leading innovative companies in Maryland. We interview the booming industry’s top executives charging forward with strong leadership and industry knowledge to bring their therapies through the clinic and eventually into patients. This series will cover companies unlocking endless possibilities and creating cell and gene therapy cures for cancers, autoimmune diseases, neurodegenerative diseases, and more. Hear their stories and learn how they’ve beat the odds and successfully push therapies into a competitive marketplace.

 

youtube-video-thumbnail
BXP's C.J. Overly Discusses the Property and Real Estate Climate of DNA Valley
youtube-video-thumbnail
Maryland Tech Council's CEO Kelly Schulz on Entrepreneurship & Biotech Industries in Maryland
youtube-video-thumbnail
Michael Richman on NextCure’s Cancer Treatment Innovations and the Rise of Biotech in Maryland
How a Disconnected Ecosystem Became the Next Big Thing: The BioHealth Capital Region
youtube-video-thumbnail
Chris Frew on Workforce Development in Maryland's Booming Biotech Industry
John Trainer on NexImmune's T Cell Technology & the Rapid Growth of Biotech in Maryland
Biochat with Jeff Galvin and Montgomery County Executive Marc Elrich

Subscribe to Our Newsletter

Subscribe to our newsletter to keep up to date with all the latest news about American Gene Technologies!

Follow AGT on Social Media

AGT on Facebook

Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. loom.ly/96TZ0jU#HIV #celltherapy #biotech ... See MoreSee Less
View on Facebook
M&A has been steady in 2024. We count 47 private & public deals to date totaling $53 billion. 15 have been >$1 billion with cancer, rare disease & cell therapies some of the areas of interest. ... See MoreSee Less
View on Facebook
AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on the research and what lies ahead in our mission to find a cure for HIV! loom.ly/jAThqIU#HIV #hivcure #HIVresearch #clinicaltrials ... See MoreSee Less
View on Facebook
Can genetic evidence make drugs more effective? A new study in Nature suggests YES. Drug mechanisms with genetic support have a 2.6x higher chance of success. loom.ly/NxSxjXk#genetics #science #Healthcare ... See MoreSee Less
View on Facebook